Biomarker Discovery May Improve Autoimmune Disease Treatment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
- Approval is based on results from the Phase 3 SELECT-AXIS 2 pivotal clinical trial in which RINVOQ delivered rapid and meaningful disease control, meeting the primary endpoint of ASAS40 response at. | May 9, 2023
A small minority of patients with long-standing ankylosing spondylitis and fused sacroiliac joints lack syndesmophytes and were more likely to be HLA-B27 positive and female, a study found.
Factors Differ for Early vs Late TNFi Switch in AS Patients medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.